abstract |
Provided herein are 2,5-disubstituted arylsulfonamides and pharmaceutical compositions thereof useful for modulating CCR3 activity. Also provided herein are methods of their use to treat, prevent or ameliorate one or more symptoms of a CCR3-mediated disorder, disease or condition. [Selection figure] None |